NASDAQ · OMDA

Omada Health, Inc.

$20.58 +$0.05 (+0.24%) 1D After hours

Key Metrics

$1.22B
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow
Beta · 1Y 1.17
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 11
    From its Jan 30 high, the share price fell 27%.

    Peak close $14.95 on Jan 30; trough close $10.94 on Feb 11. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -27%
  • Feb 5
    The stock moved -11.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 5
  • Feb 3
    The stock moved -11.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.22B
Enterprise value
Shares outstanding59.4M
52-wk range$10.28 – $26.92
Avg volume · 20D988.3K
Net cash
Book value / share$3.94
IndustryServices-Health Services
ExchangeNASDAQ
About Omada Health, Inc.
IPO dateJun 6, 2025
Employees943

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio3.92
Quick ratio3.87
Debt / equity
Debt / EBITDA
Net cash
Working capital$200.75M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings